Skip to content
Clinical Trials – home
EstoniaBack to Estonia

Clinical trials in Kohtla-Jarve Linn

6 clinical trials in Kohtla-Jarve Linn, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.

EstoniaOur site in EstoniaKliinilisedUuringud.ee(opens in a new tab)
Kohtla-Jarve Linn at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Kohtla-Jarve Linn

Open in trial search
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Urogen Pharma Ltd.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Poloxamer 407
  • Sponsor:Urogen Pharma Ltd.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Meiji Seika Pharma Co. Ltd.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB

Other cities in Estonia

The busiest research cities in the country

All 11 cities in Estonia

Clinical research in Kohtla-Jarve Linn

What the registry says about research in the country

01 Urological Oncology

Innovative research focusing on Non-Muscle Invasive Bladder Cancer treatments, evaluating novel therapeutic approaches for tumor ablation and management.

  • Bladder Cancer Treatment
  • Novel Therapeutic Formulations
  • Minimally Invasive Approaches

Multiple studies are exploring new treatment options to improve patient outcomes in early-stage bladder cancer.

02 Urinary Tract Infections

Clinical investigations into treatment options for complicated urinary tract infections and acute pyelonephritis, comparing various antibiotic combinations.

  • Advanced Antibiotic Therapies
  • Treatment Efficacy Studies
  • Infection Management

Research aims to establish more effective treatment protocols for severe urinary tract infections.

03 Diabetic Complications

Studies evaluating treatments for diabetic foot infections, comparing novel antibacterial agents to established therapies for improved patient care.

  • Infection Management
  • Comparative Drug Studies
  • Clinical Response Assessment

Focus on developing more effective treatments for moderate to severe diabetic foot complications.

04 Emergency Medicine

Research on anticoagulation reversal in urgent surgical situations, evaluating new agents for managing bleeding risks in patients on specific blood thinners.

  • Surgical Emergency Management
  • Bleeding Control
  • Patient Safety Protocols

Studies aim to improve safety during urgent procedures for anticoagulated patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).